Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : HISC -- Homeland Integrated Security Systems Inc. -- Ignore unavailable to you. Want to Upgrade?

To: jmhollen who wrote (650)	7/25/2005 6:21:04 PM
From: MJ	Read Replies (1) \| Respond to of 1970

Hi jmHollen Berkshire maybe some day? Let me know how you do. I took a day off of the market today---just checking now. Just a tip here----------I am truly great at uncovering stocks to buy. This wasn't my pick it just popped up and I was curious and followed the brick road to HISC. Hope this one works. mj

To: jmhollen who wrote (650)	7/26/2005 7:18:13 AM
From: rrufff	Read Replies (2) \| Respond to of 1970

You may have timed it just right. This won't help HISC, except peripherally. IMX - gets its first major order for its handheld Quantum Sniffer. China. This shouid be huge for IMX. Implant Sciences Receives Order for 101 Handheld Explosives Detection Systems Tuesday July 26, 6:00 am ET Quantum Sniffer Handheld Explosives Detection Equipment to Be Deployed for China Railway Project WAKEFIELD, Mass.--(BUSINESS WIRE)--July 26, 2005--Implant Sciences Corporation (AMEX: "IMX", "IMX.WS") a developer, manufacturer and marketer of products for national security, medicine and industry, today announced the receipt of a multi-million dollar purchase order from Beijing Ritchie's Time Co., Ltd, the Company's distributor in China, to deliver 101 Quantum Sniffer handheld explosives detection units. We understand that the Quantum Sniffer will be sold to the Chinese Railway Administration for use in a large railway security project in China. We expect the equipment to be delivered during our next quarter. The terms of the purchase order provide for a thirty percent (30%) advance cash payment, which has been received by the Company. Implant's Quantum Sniffer technology is differentiated from competitive products as a result of being a non-contact device that detects most explosives vapors directly as opposed to hand wiping of all trace explosives particles as competitive products presently do. The Quantum Sniffer products are being marketed for use in the detection of trace residues of explosives material for aviation and transportation security, protection of high threat facilities, infrastructure, customs and border protection, and cargo screening. Dr. Anthony J. Armini, PhD., CEO of Implant Sciences, commented, "Over the past several months we have focused our efforts on promoting and raising the level of awareness of our Quantum Sniffer explosives detection equipment in Europe, the Middle East, Asia and Australia. We believe this first large order placed for our Quantum Sniffer explosives detection equipment is the result of months of hard work by our sales team and are hopeful that we will be successful in receiving continued large awards from targeted domestic and international prospects. In recent times, it appears clear that railways have been targeted for terrorist activities. We believe the deployment of our Quantum Sniffer as part of the China Railway project should provide the Company the ability to demonstrate the capabilities of our technology for possible use in railway security applications worldwide." Dr. Armini further stated, "Implant is committed to the continued expansion of our distribution network both domestically and internationally to further penetrate the multi-billion dollar security marketplace. In addition, we have expanded our Quantum Sniffer production lines over the last 2 months and we believe we are now ready to manufacture and ship Quantum Sniffers at a rate of approximately 40 to 50 units per month." About Implant Sciences Implant Sciences, incorporated in 1984, is using its core ion technology to develop, manufacture and market products for the homeland security, semiconductor and medical device industries. The Company has developed and commercialized portable and bench-top trace element detection devices to identify explosives. In addition, to its other cancer treatment products the Company recently received an FDA 510k approval for its new radioactive source for the use in the treatment of breast cancer. For further details on the Company and its products please visit the Company's website at www.implantsciences.com. Implant Sciences believes that this release contains forward-looking statements that are subject to risks and uncertainties. Such statements are based on management's current expectations and are subject to facts that could cause results to differ materially from the forward-looking statements. For further information you are encouraged to review Implant Sciences' filings with the Securities and Exchange Commission. -------------------------------------------------------------------------------- Contact: Aurelius Consulting Group: Dave Gentry, 407-644-4256 dave@aurcg.com www.runonideas.com or Implant Sciences Corporation: Anthony Armini, 781-246-0700 aarmini@implantsciences.com www.implantsciences.com -------------------------------------------------------------------------------- Source: Implant Sciences Corporation